Annual report pursuant to Section 13 and 15(d)

Net Loss Per Common Share (Tables)

v3.21.4
Net Loss Per Common Share (Tables)
12 Months Ended
Sep. 30, 2021
Net Loss Per Common Share  
Schedule of anti dilutive securities excluded from the computation of diluted weighted average shares

The following potentially dilutive securities outstanding for the year ended September 30, 2021 and 2020 have been excluded from the computation of diluted weighted average shares outstanding, as they would be anti-dilutive:

As of September 30, 

    

2021

    

2020

Common stock purchase options

7,397,154

 

6,190,790

Restricted stock units

10,000

 

Common stock purchase warrants

895,939

 

820,939

8,303,093

 

7,011,729